Aripiprazole

Form: Intramuscular (IM) Injection

Strength: Short-acting: 9.75 mg/1.3 mL; Long-acting: 300 mg, 400 mg (monthly)

Reference Brands: Abilify(EU & US)

Category: Antipsychotropic Drugs

Aripiprazole is an atypical antipsychotic used to treat schizophrenia, bipolar disorder, depression adjunct, and autism-related irritability. It is available in multiple dosage forms including oral tablets (2–30 mg), orally disintegrating tablets, oral solution (1 mg/mL), and IM injections (short and long-acting). Brands like Abilify and Abilify Maintena are widely marketed in the US and EU. Long-acting injectable forms (300 mg, 400 mg) are particularly preferred in maintenance therapy. Pharmaceutical distributors and bulk buyers source aripiprazole in various formulations for hospital use, psychiatric facilities, and retail pharmacy networks. Reliable GMP-compliant manufacturers offer consistent global B2B supply.